Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the usual study details, showing a generic error screen.SummaryDifference18%

- Check35 days agoChange DetectedThe page’s revision indicator was updated from v3.6.5 to v3.6.6, replacing the previous revision tag to reflect a small update to the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision has been updated from v3.6.4 to v3.6.5, indicating a new revision release of the study record.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows a new revision label v3.6.4, replacing the previous v3.6.3, indicating a small update to the page metadata.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision: v3.6.3 has been added and the previous revision v3.6.2 removed, updating the page's version identifier. This is an internal software version update and does not alter the displayed study information or user-facing content.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page shows an updated Revision tag from v3.6.0 to v3.6.2. This indicates a minor internal update to the page's software/versioning and does not change the study information presented.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.